A surprisingly simple method of making unlimited copies of DNA fragments conceived under unlikely circumstances during a moonlit drive through the mountains of California.
Historical background
Although DNA was first isolated in 1869 by Miescher, its double helix structure was not described until 1953 by Watson and transferred (blotting) from the gel to a solid support (usually a nitrocellulose or nylon filter). The sequence of interest can then be detected using a short fragment of DNA (oligonucleotide probe), which is complementary to the DNA sequence of interest (hybridisation).
Initially, radioactive labels (32P, 35S, 3H) were used for probing, but later non-isotopic labels including biotin, digoxigenin, and fluorescein were employed. Three nucleic acid labelling methods are now described, including enzyme incorporation, chemical derivitisation, and chemical cross linking. The enzymatic labelling reactions for DNA include nick translation, random priming, and 5' and 3' end labelling using DNA polymerase, Klenow polymerase, and Dnasel.5 For RNA detection, riboprobes can be created using SP6, T3, and T7 in vitro enzymologies. Alternatively, synthetic oligonucleotides can be conveniently used as probes for DNA and RNA detection assays. Additionally, PCR probe labelling methods, employing biotin, digoxigenin or fluorescein labelled dNTPs in substituted molar ratios in the PCR reaction mix, can also be used for generating probes for any hybridisation analysis.
A The initial PCR method used the Klenow fragment of Escherichia coli DNA polymerase I to extend the annealed primers. As this enzyme is inactivated by the high temperatures used to melt (denature) DNA strands, it had to be replenished during every cycle after each denaturation step. With the discovery of thermostable DNA polymerases such as Taq (Thermus aquaticus) polymerase, the PCR process became simpler, obviating the need for fresh enzyme addition after each heating step. In addition, these enzymes are active at higher temperature, thus increasing specificity and the rate of DNA synthesis. '7 18 The subsequent automation of the PCR process using dedicated DNA thermal cyclers and its simplicity and ease of use led to its widespread application in disparate scientific disciplines such as cell biology, and medical specialties such as forensic medicine and tumour pathology. The impact of this development on research was acknowledged by honouring PCR with the title "Major scientific development of 1989" and Taq DNA polymerase "Molecule of the year 1989" by Science.'9 Since then, there has been an explosion in the number of publications dealing with PCR applications.
Owing to financial impact, PCR technology has been the subject of ongoing litigation. Cetus, the US biotechnology company was originally granted the patent to Southern blot DNA detection, large amounts of DNA are required, which in many cases may not be available. Indeed, archival paraffin wax embedded material up to 40 years old has been successfully used for DNA amplification, using PCR technology. 27 Tissues for histopathological examination are usually fixed in a suitable fixative to maintain morphology. The commonly used formaldehyde fixatives nick DNA and thereby reduce the maximal size of product that can be amplified. Good yields of nucleic acid can however be obtained using proteolytic enzymes such as proteinase K or pepsin.
The alcohol based fixatives (Carnoy's, methanol, methanol:acetic acid) also accommodate PCR amplification to greater or lesser degrees, while mercuric chloride based fixatives largely inhibit PCR. 28 The age of source material for PCR appears limitless. Even palaeobiological plant matter, up to 20 million years old has been used. 29 DNA and RNA can be extracted from specimens by a variety of well described techniques.30 The the first step, an RT-PCR is performed that amplifies cDNA representing all poly mRNA present in two different samples (X and Y). The PCR produces 3' cDNA stubs of approximately 200-600 base pairs that can be amplified through multiple rounds of PCR while maintaining the gene expression profile present in the starting mRNAs. 41 The second step involves the reciprocal removal of common sequences from both samples using a biotin-avidin cDNA subtraction protocol. Subtraction product X -Y is enriched for sequences present in X but not in Y and similarly Y -X is enriched for sequences in Y, not found in X. The final step of the reaction involves labelling of the subtraction products X -Y and Y -X, which are used to screen replica filters from a full length library. cDNA clones are selected that hybridise consistently with one and not the other subtracted probe.
REPRESENTATIONAL DIFFERENCE ANALYSIS
Representational difference analysis is a new technique that allows the identification of the differences between two complex genomes.4"
The technique basically involves a genomic subtractive hybridisation protocol, which allows the investigator to discriminate sequences present in a tumour specimen form normal control DNA of the same individual.
IN SITU PCR
In situ PCR is, for most histopathologists, the marriage of standard histopathology and molecular biology.43 In situ PCR is used to detect single copy target nucleic acid sequences in fixed tissues and cells. It aims to correlate PCR results with morphology. While holding the greatest potential for diagnostic histopathology, it is a technique that needs to gain widespread acceptance. The major advance of PCR is that it can amplify a sequence of DNA from among the background of the entire genome (three billion base pairs in a haploid cell), making it exquisitely more sensitive than other molecular biological tools.
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